Strikingly, NOXA mRNA expression levels correlated with OS and PFI within BC patients from the TCGA dataset treated with MTA but no other type of chemotherapy (Fig. 2E, F), showing its relevance and confirming the predictive value of our data (Table 2). The gene discussed is PMAIP1; the disease is breast cancer.